Clinical trial
Receptor Occupancy Determined by PET Neuroimaging of [11C]Mirtazapine in Healthy Humans
NCT00288782 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Receptor Occupancy Determined by PET Neuroimaging of [11C]Mirtazapine in Healthy Humans
- Lead sponsor
- University of Aarhus
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2006
- Completion date
- April 30, 2007
- Enrollment
- 24
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
affective disorders, depressive disorders, mental disorders, mood disorders